2012•Zhongguo yiyuan ganranxue zazhiRequires access
Piperacillin/tazobactam in treatment of 36 patients with acute stroke-associated pneumonia
Luo Gaoquan, Xiao Fang, Xiaona Wu, Xiang Wei
Open publisher page 0 citations
Abstract
OBJECTIVE To evaluate the clinical efficacy and safety of piperacillin/tazobactam in treatment of acute stroke-associated pneumonia.METHODS A total of 36 acute stroke-associated pneumonia patients who were microbiologically diagnosed were treated with piperacillin/tazobactam with the course of 14 days,the sputum culture was re-checked after the treatment,and the clinical improvement was observed.RESULTS The effective rate of treatment with piperacillin/tazobactam was 91.7%,the bacterial eradication rate was 89.0%,the incidence of adverse reactions was 2.8%.CONCLUSION Piperacillin/tazobactam is a highly effective and safe agent in the treatment of acute stroke-associated pneumonia.